| Home | E-Submission | Sitemap | Contact Us |  
Exerc Sci > Volume 32(2); 2023 > Article
Kim, Kang, and Park: Effects of Resistance Exercise Training on Aged Skeletal Muscle: Potential Role of Muscle Stem Cells

Abstract

PURPOSE

The prevalence of sarcopenia, which can lead to disability, hospitalization, and death, is increasing among older populations. Resistance exercise training (RT) is currently the most effective strategy for combating sarcopenia by stimulating hypertrophy and increasing strength. This review describes the underlying mechanisms of aging skeletal muscle and whether RT attenuates aging-related loss of muscle function and mass.

METHODS

We reviewed and summarized previous research using PubMed, Science Direct, and Google Scholar databases.

RESULTS

Load-induced muscle growth is a complex phenomenon that depends on various physiological systems and signaling pathways. Muscle growth occurs through signaling events arising from mechanical stress and consequent muscle protein turnover controlled by the balance between protein synthesis and degradation, which is negatively affected by aging. The authors used the myonuclear domains mediated by muscle satellite cells to explain the molecular machinery of exercise-induced muscle growth and recovery in aging muscles.

CONCLUSIONS

Despite a blunted molecular response to an exercise bout, aging muscle cells demonstrated remarkable plasticity, with substantial improvements in myofibril size and strength during RT. More studies are necessary to elucidate the specific mechanisms by which RT activates muscle satellite cells and mitogenic and myogenic signaling in aged muscles.

INTRODUCTION

Sarcopenia is defined as the degenerative, age-related reduction of skeletal muscle mass and strength [1]. Two standard deviations of skeletal muscle mass and strength below the sex-specific mean obtained from the normative young group classify an individual as sarcopenic [1]. More specific inspection using dual-energy x-ray absorptiometry (DXA) can be considered when patients are not able to rise from a chair independently, have a gait speed of less than 1 m per sec, or are bedridden. The diagnosis of sarcopenia is determined when 1) a gait speed is less than 1 m per sec; and 2) appendicular lean mass normalized to height2 is less than 7.23 kg/m2 in men and 5.67 kg/m2 in women [2]. The occurrence of sarcopenia is augmented by aging, increasing from 13% in individuals 50-70 years of age to greater than 50% in individuals more than 80 years [3]. The most severe effects of sarcopenia occur when an individual loses the capacity to remain functionally independent [4]. To overcome sarcopenia, it is crucial to understand the basis from molecular mechanisms to biological factors contributing to aging skeletal muscle.
Whereas the etiology of sarcopenia is still unknown with multifacto-rial and complex causes, the progression of sarcopenia is partially driven by a failing compensatory effort to delay degenerative processes which can impair mitogenic and myogenic mechanisms responsible for main-taining muscle protein turnover [5-7]. Specifically, aging decreases the rate of muscle protein turnover along with decreasing the protein synthesis rate of major proteins in skeletal muscle including myosin heavy chain proteins, the major contractile protein. Additional mechanisms include age-related changes in protein degradation via lysosomal, calci-um-dependent, and ubiquitin-proteasome-dependent pathways [8]. Sarcopenia may also be attributable to an overall reduction of motor units innervating muscle fibers [9].
Myonucleus plays a critical role as a transcriptional mediator of a limited region of sarcoplasm [10]. The myonuclear domain theory demon-strates the limited region to which each myonucleus can manage cellular activity in the sarcoplasm. The addition of a new nucleus occurs following the stimulation of muscle stem cells (i.e., satellite cells). Rando et al. [11] reported that satellite cells are quiescent in adult muscle in normative conditions, but can be activated to proliferate themselves in response to muscle damage or disease. It is hypothesized that the number of satellite cells varies by age, with a greater reduction of satellite cell numbers and an impairment of regenerative capacity over advanced aging [12]. In addition to the intrinsic properties of aging satellite cells, the extrinsic environment resulting from impaired satellite cell function also attenuates regenerative potential of aged muscle [13]. In the first half of this review, the author describes several major mechanisms of the loss of muscle mass; and the underlying mechanisms by which resistance exercise training (RT), the most effective natural strategy, impacts aging muscle. The rest of the review focuses on the myonuclear domain theory with muscle satellite cells and the RT-induced growth response including mitogenic, and myogenic systems in light of the aging process.

METHODS

Searched the PubMed, Science Direct, and Google Scholar databases, the author collected and summarized previous studies published from 1980 to 2023 using both clinical and non-clinical models. The keywords were ‘ aging skeletal muscle and sarcopenia’, ‘ myofiber dimension and protein turnover’, ‘ resistance exercise and aging muscle’, ‘ myonuclear domain theory and satellite cell’, and ‘ mitogenic and myogenic response to exercise’.

RESULTS

1. Underlying Mechanisms of Aging Skeletal Muscle

1) Age-related Changes in Muscular Strength

Total force production is reduced as muscle mass declines with age [14]. Cross-sectional studies indicated an 8-15% loss of absolute strength per decade after the age of 50 [15]. Longitudinal studies also presented annual decreases in absolute strength ranging from 1.4-5% annually [16]. However, evidence on the age-related reduction in specific force or the force per fiber cross-sectional area (CSA) differs from the one in absolute force. Close et al. [17] demonstrated that the specific P0 force (maximum tetanic force/cm2) for the soleus and extensor digitorum longus muscles of adult mice was within the normal specific P0 range of young mice. Other previous studies also showed no aging effect on the specific P0 for the soleus and anterior tibialis muscles of rats [18]. Despite the variety of factors contributing to a reduction in absolute strength, longitudinal data suggested that most of the variance in absolute strength decrements were associated with reductions in CSA. A decrease of 1 cm2 in muscle CSA is equal to a 2.68 N/m reduction in strength [16].
Changes in relative strength may be associated with the atrophy of type II muscle fibers rather than type I fibers, which express 1.8 times lower intrinsic force than type II fibers [19]. Kosek et al. [20] demonstrated that type II fibers possess a greater capacity for hypertrophy following resistance exercise than type I fibers with varied sex responses. These findings denoted that sex and age differences in lean body mass and strength are highly associated with their relationship to the greater hypertrophic capacity of type II fibers. This may imply that aging decreases type II muscle fibers greater than type I fibers, and women have lower type II muscle fibers compared to men. The age-related decrease in force production is also attributable to other factors such as age-related increases in fat and connective tissue [21] or decreases in functional motor units [22]. This theory is partially supported by the fact that gradual impairments in the excitation-contraction coupling process have a negative effect on the number of formations of actin-myosin cross-bridges [16].
In addition to a decrease in force production, previous studies indicated that decreases in muscle power begin earlier than strength at around 30-40 years old [23]. Moreover, previous research demonstrated a 10% reduction in power along with reductions of thigh muscle mass at a 4% loss every decade and maximal velocity at a 6% loss every decade [24]. The velocity of contraction strongly relates to the total power output of muscle, given that power is calculated by averaged force production and shortening velocity [14]. Whereas the velocity of contraction may corre-late with myosin adenosine triphosphate (ATP)-ase activity, compared to young, aged skeletal muscles demonstrated little change in the activity of contractile enzymes [25]. The selective atrophy of fast twitch muscle fibers [26], partial denervation of fast twitch motor units [27], and impaired excitation-contraction coupling [28] may account for age-related changes in power.

2) Age-related Changes in Myofiber Dimensions

Aging-related atrophy most likely appeared in type II muscle fiber CSA with little changes in type I fiber CSA [29]. Age-associated myofiber atrophy might involve both type IIA and B fibers [30]. Compared to total decreases in muscle mass, decreases in single fiber size are moderate, implying that there is also a reduced number of muscle fibers [31]. Interestingly, Lexell et al. [32] demonstrated that aged human muscles possessed ∼50% fewer type IIA and B fibers compared to young muscles. Additionally, this study [32] showed an accelerated 30% loss of muscle tissue from age 50 to 80, which was mostly driven by decreases in the number of fibers. Aniansson et al. [33] using an 11-year longitudinal study demonstrated specific fiber type changes in men over 70 years of age. While type I fiber size showed no change, the participants showed 14% and 25% size reductions in type IIA and IIX fiber, respectively, on 7-year follow-ups.

3) Age-related Changes in Muscle Protein Turnover

Aged muscles have a reduced capacity to recover and attenuated hypertrophic responses [34,35]. Sarcopenia and the loss of muscle mass can be partially explained by an imbalance between protein synthesis and degradation and impaired regenerative capacity [8]. The respective synthesis of different muscle cell proteins (e.g., myofibrillar, sarcoplasmic, and mitochondrial proteins) contribute to the synthesis of total muscle protein. Previous research indicated ∼28% decrease in myofibrillar protein synthesis rates in the elderly; however, sarcoplasmic proteins re-mained unchanged [36]. Similarly, other studies showed, compared to young and middle-aged subjects, the older demonstrated unchanged sarcoplasmic protein synthesis in skeletal muscles. In contrast, mitochondrial and myofibrillar protein synthesis rates decreased by 31% and 40%, respectively, in middle-aged subjects compared to the young [37]. These findings were supported by a rodent study [38] with the decreased rate of protein synthesis in the gastrocnemius muscle of aged rats compared to young. However, Mosoni et al. [39] found no age-related chang-es in muscle protein synthesis. More studies are necessary to elucidate 1) whether aging impacts the basal or postprandial levels of protein synthesis rate; and 2) whether those levels differ between specific compart-ments of the cell (i.e., myofibrillar, sarcoplasmic, and mitochondrial).

4) Age-related Changes in Muscle Protein Degradation

While age-related changes in protein synthesis are somewhat equivo-cal, clear changes in protein degradation may account for the age-related loss in muscle mass [40]. Several major proteolytic pathways (i.e., lysosomal-, calcium-, caspase-, and ubiquitin proteasome-dependent pathways) possibly change with age and sarcopenic state [8]. Skeletal muscle contains lysosomes which contain digestive enzymes that can break down excess or aged organelles in addition to engulfing viruses or bacte-ria. Changes in the lysosomal pathway affect the capacity to maintain a highly functional cellular environment in aging cells. The lysosomal pro-teases such as cathepsins are responsible for the degradation of aged membrane-bound proteins or organelles [41]. Several pathways deliver intracellular protein substrates to lysosomes: chaperone-mediated au-tophagy (CMA), micro-, and macro-autophagy [42]. Kiffin et al. [43] found that rates of CMA decreased with aging, which was attributed to decreased levels of lysosome-associated membrane protein type 2A (LAMP-2A), a receptor allowing particular cytosolic proteins to be trans-ported to lysosomes. Cuervo et al. [44] also found a decreased CMA and macro-autophagy activity due to aging. CMA plays a critical role in the lysosomal degradation of particular cytosolic proteins which are deliv-ered into the lysosomal lumen after crossing the lysosomal membrane [45]. Although low basal CMA levels were found in many aging cells, altered CMA activity also exists under conditions of stress (oxidative stress, cellular exposure to toxic compounds, and prolonged starvation).
Alteration of calpain, a calcium-dependent cysteine protease enzyme, may contribute to the impaired proliferation rate of satellite cells in aged muscle fibers, specifically by the modification of cell cycle progression [8]. There are three major muscle specific calpain isoforms: ubiquitous calpain-1 (µ-calpain), −2 (m-calpain), and calpain-3 (p94) [46]. Dargelos et al. [47] indicated that calpain is a major regulator in myogenesis due to its ability to remodel cytoskeletal anchorage complexes. Calpain also belongs to regulatory factors for apoptosis. A substantial elevation of cal-cium-associated proteolytic activity and a decrease in endogenous in-hibitors of calpain were found in the muscles of aged rats. Calpains may contribute to the reduced proliferation rate of satellite cells in aged individuals [8]. More research is needed to demonstrate the role of calpain in the aging-associated loss of muscle mass.
Increased activity of the ATP-ubiquitin-dependent proteolytic pathway has been reported in muscle-wasting condition such as renal failure, sepsis, acidosis, and cancer [48-52]. The linkage of ubiquitin to proteins occurs in a variety of steps requiring the activation of specific enzymes. The E3 ubiquitin ligases are one of the major enzymes in this process. Three of these ligases, E3α-II and ligases encoded by the genes of muscle RING-finger protein (MURF)-1 and muscle-atrophy F-Box protein (MAFbx), also known as Atrogin-1, are broadly distributed in skeletal muscles [53]. Whereas few studies demonstrated the critical role of ubiq-uitin-proteasome signals in aged skeletal muscle, conflicting results have involved no changes [54], decreases in ubiquitin activity [55], and decreases limited to the trypsin-like activity [54]. Humson et al. [56] presented ∼60% decreases in all three proteolytic activities along with the decreased activity of specific proteasomes in aged muscles. In line with these findings, Edstrom et al. [57] also demonstrated the down-regulation of MAFbx and MuRF1 in aged muscles.

2. Effects of Resistance Exercise Training (RT) on Aged Skeletal Muscle

1) Muscle Activation during RT

RT in the elderly has been demonstrated to augment performance in activities of daily living, movement balance [58], and gait speed [6]. These improvements may be attributed to muscle fiber hypertrophy [59] and the augmentation of strength [60]. During RT, the neuromuscular interaction may determine the amount of force exerted and the muscle fibers activated. The Henneman's size principle demonstrated the close relationship between motor unit size and strength. The neural recruitment of muscle fibers begins with the small motor units and then pro-gresses to larger motor units until force production meets force require-ments. Low-force activity primarily recruits type I muscle fibers, and high-force activity such as resistance exercise additionally recruits the type II fibers [61]. Electromyographic activity is greater after performing explosive concentric muscle actions with a light load (40% of peak isometric force) compared to performing the same exercise with a heavy load (67% of peak isometric force) at a slower velocity. This implies that rapidly accelerating the load augments muscle force production, and increasing contraction velocity is a better exercise strategy to stimulate type II fibers than increasing load [62].
The rate of force development, exercise load, and muscle fatigue affect the type of motor unit recruitment during RT [63]. It is important to consider that only recruited motor units may respond and adapt to RT. Moreover, type I and II fibers have different signaling responses with type II fibers having a characteristically greater hypertrophic response than type I fibers [64]. The percentage of fiber types varies depending on the type of muscle fibers utilized (e.g., gastrocnemius has up to 60% type II muscle fibers, while the soleus has approximately 85% of type I fibers) [65]. These findings demonstrated the major factor that exercisers may consider when they develop their RT program to enhance type II fibers.

2) RT-induced Changes in Muscle Mass and Strength of Aged Muscles

RT can generate robust increases in muscle mass and strength in young populations, but also considerable effects were found in elderly populations. RT is currently the most effective strategy to prevent the age-related decrease in muscle strength and mass [66]. Despite the age-related impairments in molecular machinery, research have shown that frail old individuals more than 70 years of age experienced robust increases in mixed-muscle protein synthesis and structural muscle protein following the RT program [58,67]. In older adults, the RT regimen also produced significant increases in type II myofiber CSA and the proportion of type IIa fiber distribution [68]. With respect to strength gains, RT robustly increased isometric and dynamic absolute strength (7% to 36% and 60% to 260%, respectively) in older subjects [6]. In addition to absolute strength, RT also has been demonstrated to increase relative force. Reeves et al. [69] reported that RT for 14 weeks at a frequency of 3 sessions per week resulted in a 19% increase in force per unit area (N/cm2).
Kosek et al. [20] initially found that type II fibers have a greater capacity for hypertrophy following RT than type I fibers, and this hypertrophic response varied amongst both sexes. They investigated the effects of 16-week moderate to high-intensity RT (60-85% 1RM) at a frequency of 3 bouts per week in older men and women. Results showed a main sex effect with greater increases in type IIA myofiber CSA in older men following RT regimens compared to almost no changes in older women. Future studies are needed to investigate the sex difference in the RT-in-duced muscle hypertrophy, and its underlying mechanisms regarding sex hormones.

3. Underlying Mechanisms of RT-induced Growth Responses in Aged Muscle

1) Myonuclear Domain Theory

Myonucleus plays a critical role in major transcriptional regulations for a limited region of sarcoplasm, called the myonuclear domain theory [10]. Following the physical or chemical activations of muscle stem cells (i.e., satellite cells), the addition of new myonuclei occurs. In a normative state, satellite cells are usually quiescent. When high force-mechanical stress stimulates myofibers, satellite cells are activated. Consequently, satellite cells continue to proliferate and migrate into sarcoplasm, followed by the differentiation into newly elongated myotubes or fusion into damaged myofibers [10].
The pool of satellite cells is well maintained almost for six to seven de-cades in humans [70] and then gradually decreases over time [71]. In addition to the number of satellite cells, the function can be also impacted by the aging process with the blunted responses of activation and proliferation to exercise-induced muscular stress or mechanical damage [72]. Endocrines and the locally produced growth factors, autocrine and paracrine, are strongly related to mechanisms initiating and incorporating satellite cells into activated myofibers following muscular stimuli [73]. The blunted responses of aged muscle may be explained partially by the aging-related decreases in endocrine anabolic factors [74], and also by the impaired local milieu around damaged tissues [75]. Whereas the negative effect of aging exists in the number and function of satellite cells, RT has been used as an effective strategy to overcome the aging impact on satellite cells. The RT-induced expansion of fiber volume appears to accompany a significant enhancement of the number of myonuclei and satellite cells in aged muscle [76].
The neural cell adhesion molecule (CD56) is a developmental molecule abundantly expressed on the surface of embryonic myotubes [77], and also expressed on quiescent, active, and proliferating satellite cells [71]. Although there are other markers of satellite cell presence such as m-cadherin, Pax-7, c-met, myf-5, and myo-D, no specific markers delin-eating the state of proliferation or differentiation exist [78]. Among the Pax family of transcription factors, especially Pax7 plays important role in patterning and cell fate determination during embryonal development [79]. Pax7 is located in the nucleus of the satellite cells, while CD56 is presented on the membrane of the satellite cell [80]. Pax7 was used to demonstrate the satellite cell activation and proliferation following downhill running in rats, and immunohistochemical analysis revealed that the exercise group displayed augmented numbers of myofibers con-taining activated and proliferating satellite cells [81]. Petrella et al. [7] reported that the greater number of myonuclei and satellite cell addition along with the RT-induced hypertrophy observed in aged men and women using the CD56-stained satellite cells.

2) Mitogenic Response to Loading Stimuli and Aging

Several components of intracellular signaling pathways are sensitive to aging. Mitogens, insulin-like growth factor (IGF)-I and mechano-growth factor (MGF, also called IGF-Ec), are locally produced growth factors and sensitive to mechanical stimuli, and can induce cells to begin cell di-visions. Phosphorylation of the ribosomal protein p70 S6 kinase (S6K1) serves as a key regulatory step for increased translational capacity. Inten-sified loading and ligand-bound IGF-I receptors augment S6K1 phos-phorylation [82]. The proliferation and differentiation of satellite cells can be stimulated by phosphoinositol-3-kinase protein kinase B (PI3K-AKT) and mitogen-activated protein kinase (MAPK) signals. Both IGF-I and MGF expand the myonuclear domains through translation-induced protein accretion, and then enhance further growth via the stimulation of mitogenic and myogenic processes of satellite cells [83].
Compared to young rats, aged F/BNF rats showed greater IGF-I mRNA expressions in the gastrocnemius muscle at basal level [84]. This data of elevated basal levels is supported by a study by Adams et al. [85] demon-strating 20% greater IGF-I mRNA levels at resting in the muscles of aged rats compared to young rats. Aged rats exhibited attenuated elevations of IGF-I mRNA expression following an acute resistance exercise bout compared to young rats, implying a blunted mitogenic response following a single bout of exercise [85]. It is speculated that elevated IGF-I levels at basal state might be a compensatory mechanism of the blunted response to exercise. However, despite the aging-related attenuation of exercise response, Petrella et al. [7] found that 16 weeks of chronic RT regimen still strongly increased an IGF-I response to a single bout of resistance loading in humans (pre-RT: 29% vs. post-RT: 85%).
Similar to the blunted IGF-I response to a single bout of exercise in aged muscle, previous research has demonstrated that aging attenuates the load-induced elevation of skeletal muscle MGF expressions. Using a rodent model, Owino et al. [86] demonstrated that aging appears to be strongly associated with impaired MGF responses to acute external loading. Old Sprague Dawley rats at 24 months of age demonstrated an attenuated increase in MGF mRNA expression induced by tenotomy overloading on plantaris compared to young rats at 3 months of age [86]. In human muscles, a single bout of resistance loading may upregulate MGF mRNA expression promoting greater satellite cell activation in the young compared to sarcopenic old adults [73]. Petrella et al. [7] found a two-fold higher magnitude of increase in MGF mRNA expression following 16 weeks of resistance training in young (85%) compared to old adults (40%). More studies are necessary to demonstrate the effect of acute and chronic RT on IGF-I and MGF response, and whether a similar trend can be found in protein content levels assessed by Western Blots.

3) Myogenic Response to Loading Stimuli and Aging

Myogenic differentiation factor (MyoD), myogenic factor (Myf)-5, and myogenin are the myogenic regulatory factors (MRFs) that are com-monly studied as myogenic markers for satellite cell differentiation [87] and differentiated myofiber phenotypes [88]. Several studies reported an up-regulation of MRFs in response to a variety of muscular perturbations pertaining to ablation [82], myotoxicity [89], stretch overload [90], and acute resistance loading [73,91], implying the important role of MRFs in muscle regeneration. The activation of Myf-5 and MyoD con-tributes to the mitotic division of satellite cells [92]. Whereas Myf-5 is involved in signaling for satellite cell renewal, MyoD is related to the early step of differentiation to start myogenic lineage. The research found that a failed expression of MyoD increases proliferating satellite cells and decreases the number of myotubes [92]. Kim et al. [73] demonstrated that, at resting level, greater MyoD and Myf-5 gene expression was found in older compared to the younger group. Similarly, Raue et al. [93] reported that all MRFs were over-expressed in old versus young adults at rest. After mechanical loading, old rats demonstrated lower elevation in MyoD and protein expression than young rats [91]. Higher resting levels of these genes in the older group may suggest a compensatory mechanism to overcome the attenuated response to mechanical loading.
Myogenin is a muscle-specific transcription factor which is a member of the MRF family. Myogenin regulates the end step of differentiation of satellite cells for consequent myoblast fusion [92]. At resting level, myogenin mRNA expressions were four-fold greater in the gastrocnemius of old rats compared to young rats. However, only the young rats experienced significantly elevated myogenin mRNA expression after electrical stimulation [85]. A similar trend was found in human studies. Bamman et al. [94] demonstrated 44% greater myogenin levels at rest in old compared to young adults. After a single bout of resistance exercise, old subjects exhibited 3-fold less increase (+22%) in myogenin mRNA compared to young adults (+75%) [73]. Previous research demonstrated that basal MRFs expression might be increased in the condition of advanced sarcopenia [95]. To sum up, the elevated basal level of MRFs appears man-datory to overcome the blunted regenerative response following resistance exercise loading.

CONCLUSION

Skeletal muscle and strength decline over advanced aging. Aging-related loss of muscle mass most likely appears in type II muscle fiber with little changes in type I fiber. The loss of muscle mass can be partially explained by an imbalance between protein synthesis and degradation and the impaired regenerative capacity managed by the myonuclear domain. Following the activation of muscle satellite cells, myonuclei are newly provided for muscle growth and regeneration. The function and number of satellite cells responsible for increasing the number of myonuclei are decreased with the aging process, which negatively impacts the RT-in-duced growth response including mitogenic and myogenic signaling. Interestingly, aging muscle possesses the elevated basal level of mitogenic and myogenic factors that might be providing a compensatory mechanism to overcome the blunted regenerative response following exercise loading. Whereas RT is still the most effective strategy to overcome sarcopenia, more studies should investigate the specific mechanisms by which RT activates muscle satellite cells along with mitogenic and myogenic signaling in aged muscle.

Conflict of Interest

The authors declare that there is no conflict of interest.

AUTHOR CONTRIBUTION

Conceptualization: Y Park; Writing - original draft: Y Park, D Kim, N Kang; Writing - review & editing: D Kim, N Kang.

REFERENCES

1. Melton LJ 3rd, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, et al. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000;48(6):625-30.
crossref
2. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-56.
crossref
3. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Pre-dictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing & Development. 1999;107(2):123-36.
crossref
4. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr. 2003;78(2):250-8.
crossref
5. Bamman MM, Petrella JK, Kim JS, Mayhew DL, Cross JM. Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans. J Appl Physiol. 2007;102(6):2232-9.
crossref
6. Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. Jama. 1990;263(22):3029-34.
crossref
7. Petrella JK, Kim JS, Cross JM, Kosek DJ, Bamman MM. Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women. Am J Physiol Endocrinol Metab. 2006;291(5):E937-46.
crossref
8. Combaret L, Dardevet D, Bechet D, Taillandier D, Mosoni L, et al. Skeletal muscle proteolysis in aging. Curr Opin Clin Nutr Metab Care. 2009;12(1):37-41.
crossref
9. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137(4):231-43.
crossref
10. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol. 2001;91(2):534-51.
crossref
11. Rando TA. Stem cells, ageing and the quest for immortality. Nature. 2006;441(7097):1080-6.
crossref pdf
12. Conboy IM, Rando TA. Aging, stem cells and tissue regeneration: les-sons from muscle. Cell Cycle. 2005;4(3):407-10.
crossref
13. Bortoli S, Renault V, Eveno E, Auffray C, Butler-Browne G, et al. Gene expression profiling of human satellite cells during muscular aging using cDNA arrays. Gene. 2003;321:145-54.
crossref
14. Kirkendall DT, Garrett WE Jr. The effects of aging and training on skeletal muscle. Am J Sports Med. 1998;26(4):598-602.
crossref pdf
15. Lindle RS, Metter EJ, Lynch NA, Fleg JL, Fozard JL, et al. Age and gen-der comparisons of muscle strength in 654 women and men aged 20-93 yr. J Appl Physiol. 1997;83(5):1581-7.
crossref
16. Frontera WR, Suh D, Krivickas LS, Hughes VA, Goldstein R, et al. Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol. 2000;279(3):C611-8.
crossref
17. Close RI. Dynamic properties of mammalian skeletal muscles. Physiol Rev. 1972;52(1):129-97.
crossref
18. McCarter R, McGee J. Influence of nutrition and aging on the composition and function of rat skeletal muscle. J Gerontol. 1987;42(4):432-41.
crossref
19. Narici MV, Bordini M, Cerretelli P. Effect of aging on human adductor pollicis muscle function. J Appl Physiol. 1991;71(4):1277-81.
crossref
20. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol. 2006;101(2):531-44.
crossref
21. Macaluso A, De Vito G. Muscle strength, power and adaptations to resistance training in older people. Eur J Appl Physiol. 2004;91(4):450-72.
crossref pdf
22. Stalberg E, Fawcett PR. Macro EMG in healthy subjects of different ages. J Neurol Neurosurg Psychiatry. 1982;45(10):870-8.
crossref
23. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing. 1994;23(5):371-7.
crossref
24. Kostka T. Quadriceps maximal power and optimal shortening velocity in 335 men aged 23-88 years. Eur J Appl Physiol. 2005;95(2-3):140-5.
crossref pdf
25. Barany M. ATPase activity of myosin correlated with speed of muscle shortening. J Gen Physiol. 1967;50(6 Suppl):197-218.
crossref pdf
26. Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, et al. Histo-chemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol. 1992;47(3):B71-6.
crossref
27. Vaillancourt DE, Larsson L, Newell KM. Effects of aging on force vari-ability, single motor unit discharge patterns, and the structure of 10, 20, and 40 Hz EMG activity. Neurobiol Aging. 2003;24(1):25-35.
crossref
28. Delbono O, O'Rourke KS, Ettinger WH. Excitation-calcium release uncoupling in aged single human skeletal muscle fibers. J Membr Biol. 1995;148(3):211-22.
crossref pdf
29. Bamman MM, Hill VJ, Adams GR, Haddad F, Wetzstein CJ, et al. Gender differences in resistance-training-induced myofiber hypertrophy among older adults. J Gerontol A Biol Sci Med Sci. 2003;58(2):108-16.
crossref
30. Moulias R, Meaume S, Raynaud-Simon A. Sarcopenia, hypermetabo-lism, and aging. Z Gerontol Geriatr. 1999;32(6):425-32.
crossref pdf
31. Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol. 2003;95(4):1717-27.
crossref
32. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2-3):275-94.
pmid
33. Aniansson A, Grimby G, Hedberg M. Compensatory muscle fiber hypertrophy in elderly men. J Appl Physiol. 1992;73(3):812-6.
crossref
34. Chakravarthy M, Davis B, Booth F. IGF-I restores satellite cell prolifer-ative potential in immobilized old skeletal muscle. J Appl Physiol. 2000;89:1365-79.
crossref
35. Degens H, Alway SE. Skeletal muscle function and hypertrophy are diminished in old age. Muscle Nerve. 2003;27(3):339-47.
crossref
36. Welle S, Thornton C, Jozefowicz R, Statt M. Myofibrillar protein synthesis in young and old men. Am J Physiol. 1993;264(5 Pt 1):E693-8.
crossref
37. Balagopal P, Rooyackers OE, Adey DB, Ades PA, Nair KS. Effects of aging on in vivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol. 1997;273(4 Pt 1):E790-800.
crossref
38. Kelly FJ, Lewis SE, Anderson P, Goldspink DF. Pre- and postnatal growth and protein turnover in four muscles of the rat. Muscle Nerve. 1984;7(3):235-42.
crossref
39. Mosoni L, Patureau Mirand P, Houlier ML, Arnal M. Age-related changes in protein synthesis measured in vivo in rat liver and gastrocnemius muscle. Mech Ageing Dev. 1993;68(1-3):209-20.
crossref
40. Dardevet D, Rieu I, Fafournoux P, Sornet C, Combaret L, et al. Leu-cine: a key amino acid in ageing-associated sarcopenia? Nutr Res Rev. 2003;16(1):61-70.
crossref
41. Attaix D, Mosoni L, Dardevet D, Combaret L, Mirand PP, et al. Altered responses in skeletal muscle protein turnover during aging in anabolic and catabolic periods. Int J Biochem Cell Biol. 2005;37(10):1962-73.
crossref
42. Bechet D, Tassa A, Taillandier D, Combaret L, Attaix D. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol. 2005;37(10):2098-114.
crossref
43. Kiffin R, Kaushik S, Zeng M, Bandyopadhyay U, Zhang C, et al. Altered dynamics of the lysosomal receptor for chaperone-mediated au-tophagy with age. J Cell Sci. 2007;120(Pt 5):782-91.
crossref pdf
44. Cuervo AM, Dice JF. When lysosomes get old. Exp Gerontol. 2000;35(2):119-31.
crossref
45. Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease. Curr Top Dev Biol. 2006;73:205-35.
crossref
46. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83(3):731-801.
crossref
47. Dargelos E, Poussard S, Brule C, Daury L, Cottin P. Calcium-depen-dent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia. Biochimie. 2008;90(2):359-68.
crossref
48. Bossola M, Muscaritoli M, Costelli P, Bellantone R, Pacelli F, et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol. 2001;280(5):R1518-23.
crossref
49. Filippatos GS, Anker SD, Kremastinos DT. Pathophysiology of periph-eral muscle wasting in cardiac cachexia. Curr Opin Clin Nutr Metab Care. 2005;8(3):249-54.
crossref
50. Klaude M, Fredriksson K, Tjader I, Hammarqvist F, Ahlman B, et al. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond). 2007;112(9):499-506.
crossref pdf
51. Raj DS, Shah H, Shah VO, Ferrando A, Bankhurst A, et al. Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis. 2003;42(6):1212-20.
crossref
52. Ottenheijm CA, Heunks LM, Li YP, Jin B, Minnaard R, et al. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic ob-structive pulmonary disease. Am J Respir Crit Care Med. 2006;174(9):997-1002.
crossref
53. Costelli P, Carbo N, Busquets S, Lopez-Soriano FJ, Baccino FM, et al. Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice over-expressing the c-ski oncogene. Cancer Lett. 2003;200(2):153-60.
crossref
54. Radak Z, Takahashi R, Kumiyama A, Nakamoto H, Ohno H, et al. Effect of aging and late onset dietary restriction on antioxidant enzymes and proteasome activities, and protein carbonylation of rat skeletal muscle and tendon. Exp Gerontol. 2002;37(12):1423-30.
crossref
55. French SW, Mayer RJ, Bardag-Gorce F, Ingelman-Sundberg M, Rouach H, et al. The ubiquitin-proteasome 26s pathway in liver cell protein turnover: effect of ethanol and drugs. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):225S-9S.
crossref
56. Husom AD, Peters EA, Kolling EA, Fugere NA, Thompson LV, et al. Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys. 2004;421(1):67-76.
crossref
57. Edstrom E, Altun M, Hagglund M, Ulfhake B. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61(7):663-74.
crossref
58. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994;330(25):1769-75.
crossref
59. Avlund K, Schroll M, Davidsen M, Loveborg B, Rantanen T. Maximal isometric muscle strength and functional ability in daily activities among 75-year-old men and women. Scand J Med Sci Sports. 1994;4:32-40.
crossref
60. Jette AM, Branch LG. The Framingham Disability Study: II. Physical disability among the aging. American Journal of Public Health. 1981;71:1211-6.
crossref
61. Henneman E, Somjen G, Carpenter DO. Functional significance of cell size in spinal motoneurons. J Neurophysiol. 1965;28:560-80.
crossref
62. Linnamo V, Newton RU, Hakkinen K, Komi PV, Davie A, et al. Neuromuscular responses to explosive and heavy resistance loading. J Electro-myogr Kinesiol. 2000;10(16):417-24.
crossref
63. Spiering BA, Kraemer WJ, Anderson JM, Armstrong LE, Nindl BC, et al. Resistance exercise biology: manipulation of resistance exercise pro-gramme variables determines the responses of cellular and molecular signalling pathways. Sports Med. 2008;38(7):527-40.
pmid
64. MaCall GE, Byrnes WC, Dickinson A, Pattany PM, Fleck S. Muscle fiber hypertrophy, hyperplasia, and capillary density in college men after resistance training. J Appl Physiol. 1996;81(85):2004-12.
crossref
65. Trappe SW, Trappe TA, Lee GA, Widrick JJ, Costill DL, et al. Compari-son of a space shuttle flight (STS-78) and bed rest on human muscle function. J Appl Physiol. 2001;91(91):57-64.
crossref
66. Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008;33(1):191-9.
crossref
67. Yarasheski KE, Pak-Loduca J, Hasten DL, Obert KA, Brown MB, et al. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men >/=76 yr old. Am J Physiol. 1999;277(1 Pt 1):E118-25.
pmid
68. Trappe S, Godard M, Gallagher P, Carroll C, Rowden G, et al. Resistance training improves single muscle fiber contractile function in older women. Am J Physiol Cell Physiol. 2001;281(2):C398-406.
crossref
69. Reeves ND, Narici MV, Maganaris CN. In vivo human muscle structure and function: adaptations to resistance training in old age. Experi-mental Physiology. 2004;89:675-89.
crossref pdf
70. Roth SM, Martel GF, Ivey FM, Lemmer JT, Metter EJ, et al. Skeletal muscle satellite cell populations in healthy young and older men and women. Anat Rec. 2000;260(4):351-8.
crossref
71. Kadi F, Charifi N, Denis C, Lexell J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve. 2004;29(1):120-7.
crossref
72. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Science. 2003;302(5650):1575-7.
crossref
73. Kim JS, Kosek DJ, Petrella JK, Cross JM, Bamman MM. Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women. J Appl Physiol. 2005;99(6):2149-58.
crossref
74. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005;433(7027):760-4.
crossref pdf
75. Carlson BM, Faulkner JA. Muscle transplantation between young and old rats: age of host determines recovery. Am J Physiol. 1989;256(6 Pt 1):C1262-6.
crossref
76. Allen DL, Monke SR, Talmadge RJ, Roy RR, Edgerton VR. Plasticity of myonuclear number in hypertrophied and atrophied mammalian skeletal muscle fibers. J Appl Physiol. 1995;78(5):1969-76.
crossref
77. Fidzianska A, Kaminska A. Neural cell adhesion molecule (N-CAM) as a marker of muscle tissue alternations. Review of the literature and own observations. Folia Neuropathol. 1995;33(3):125-8.
pmid
78. Thornell LE, Lindstrom M, Renault V, Mouly V, Butler-Browne GS. Satellite cells and training in the elderly. Scand J Med Sci Sports. 2003;13(1):48-55.
crossref pdf
79. Reimann J, Brimah K, Schroder R, Wernig A, Beauchamp JR, et al. Pax7 distribution in human skeletal muscle biopsies and myogenic tissue cultures. Cell Tissue Res. 2004;315(2):233-42.
crossref pdf
80. Mackey AL, Kjaer M, Charifi N, Henriksson J, Bojsen-Moller J, et al. Assessment of satellite cell number and activity status in human skeletal muscle biopsies. Muscle Nerve. 2009;40(3):455-65.
crossref pdf
81. Enns DL, Tiidus PM. Estrogen influences satellite cell activation and proliferation following downhill running in rats. J Appl Physiol. 2008;104(2):347-53.
crossref
82. Adams GR, Caiozzo VJ, Haddad F, Baldwin KM. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol. 2002;283:C1182-95.
crossref
83. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize dis-tinct signaling pathways. J Biol Chem. 1997;272(10):6653-62.
crossref
84. Severgnini S, Lowenthal DT, Millard WJ, Simmen FA, Pollock BH, et al. Altered IGF-I and IGFBPs in senescent male and female rats. J Gerontol A Biol Sci Med Sci. 1999;54(3):B111-5.
crossref
85. Haddad F, Adams GR. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J Appl Physiol. 2006;100(4):1188-203.
crossref
86. Owino V, Yang SY, Goldspink G. Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett. 2001;505(2):259-63.
crossref pdf
87. Olive M, Martinez-Matos JA, Pirretas P, Povedano M, Navarro C, et al. Expression of myogenic regulatory factors (MRFs) in human neuromuscular disorders. Neuropathol Appl Neurobiol. 1997;23(6):475-82.
crossref
88. Kadi F, Johansson F, Johansson R, Sjostrom M, Henriksson J. Effects of one bout of endurance exercise on the expression of myogenin in human quadriceps muscle. Histochem Cell Biol. 2004;121(4):329-34.
crossref pdf
89. Marsh DR, Criswell DS, Carson JA, Booth FW. Myogenic regulatory factors during regeneration of skeletal muscle in young, adult, and old rats. J Appl Physiol. 1997;83(4):1270-5.
crossref
90. Carson JA, Booth FW. Myogenin mRNA is elevated during rapid, slow, and maintenance phases of stretch-induced hypertrophy in chicken slow-tonic muscle. Pflugers Arch. 1998;435(6):850-8.
crossref pdf
91. Tamaki T, Uchiyama S, Uchiyama Y, Akatsuka A, Yoshimura S, et al. Limited myogenic response to a single bout of weight-lifting exercise in old rats. Am J Physiol Cell Physiol. 2000;278(6):C1143-52.
crossref
92. Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet. 2000;57(1):16-25.
crossref pdf
93. Raue U, Slivka D, Jemiolo B, Hollon C, Trappe S. Myogenic gene expression at rest and after a bout of resistance exercise in young (18-30 yr) and old (80-89 yr) women. J Appl Physiol. 2006;101(1):53-9.
crossref
94. Bamman MM, Ragan RC, Kim JS, Cross JM, Hill VJ, et al. Myogenic protein expression before and after resistance loading in 26- and 64- yr-old men and women. J Appl Physiol. 2004;97(4):1329-37.
crossref
95. Edstrom E, Ulfhake B. Sarcopenia is not due to lack of regenerative drive in senescent skeletal muscle. Aging Cell. 2005;4(2):65-77.
crossref
Editorial Office
The Korean Society of Exercise Physiology
Dept. of Healthcare and Science, Dong-A University, 37, Nakdong-daero 550beon-gil, Saha-gu, Busan 49315, Korea
TEL: +82-51-200-7517   E-mail: editor@ksep-es.org
Editorial Assistant: Taewan Kim +82-10-4019-0208
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Exercise Physiology.                 Developed in M2PI